🔎 Trials Near Me

Home › Mesothelioma › Washington › Seattle

Pag-aaral pangklinika para sa Mesothelioma sa Seattle, WA

6 pag-aaral para sa Mesothelioma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Seattle (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Nagre-recruitPhase 1
  • Swedish Cancer Institute, Seattle
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07277413

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Nagre-recruitObservasyonal na pag-aaral
  • Fred Hutchinson Cancer Center, Seattle
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04981119

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Nagre-recruitPhase 1/2
  • Swedish Cancer Institute, Seattle
  • Fred Hutchinson Cancer Center, Seattle
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT04104776

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Nagre-recruitPhase 1/2
  • Swedish Cancer Institute, Seattle
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT05579366

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Nagre-recruitPhase 1/2
  • Fred Hutchinson Cancer Center, Seattle
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT06051695

A Study of NX-1607 in Adults With Advanced Malignancies

Nagre-recruitPhase 1
  • Fred Hutchinson Cancer Center, Seattle
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2025 · NCT05107674

Pag-aaral para sa Mesothelioma sa ibang lungsod

Iba pang pag-aaral sa Seattle

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.